share_log

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $15 Price Target

Benzinga ·  Feb 23, 2023 03:18

HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment